-+ 0.00%
-+ 0.00%
-+ 0.00%

Nykode Therapeutics Raises NOK286 Million via Share Placement

MT Newswires·08/28/2026 01:01:22
Listen to the news
01:01 AM EDT, 08/28/2026 (MT Newswires) -- Nykode Therapeutics (NYKD.OL) said Thursday it raised 286 million Norwegian kroner through an oversubscribed private placement of 65 million new shares at a subscription price of 4.40 kroner each. The biopharmaceutical company plans to use the proceeds to strengthen its position for potential partnering through the development of VB.10.NEO and manufacturing improvements, accelerate its cancer vaccine abi-suva's transition from phase 2 to phase 3, and evaluate its expansion into locally advanced settings. The funds will also support the development of Nykode's tolerance platform, including the selection of a lead program in the first half of 2027, and general corporate purposes. ABG Sundal Collier, Arctic Securities, and DNB Carnegie acted as joint global coordinators and bookrunners in the placing.